Novel N1-(benzyl)cinnamamidine derived NR2B subtype-selective NMDA receptor antagonists
- 1 February 2003
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 13 (4) , 693-696
- https://doi.org/10.1016/s0960-894x(02)01060-0
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Orally Efficacious NR2B-Selective NMDA Receptor AntagonistsBioorganic & Medicinal Chemistry Letters, 2003
- NR2B Selective NMDA Receptor AntagonistsCurrent Pharmaceutical Design, 2002
- NMDA receptor antagonists as analgesics: focus on the NR2B subtypePublished by Elsevier ,2001
- Copper(I)-induced addition of amines to unactivated nitriles: The first general one-step synthesis of alkyl amidines.Published by Elsevier ,2001
- Characterisation of N‐Methyl‐D‐Aspartate Receptor‐Specific [3H]Ifenprodil Binding to Recombinant Human NR1a/NR2B Receptors Compared with Native Receptors in Rodent Brain MembranesJournal of Neurochemistry, 2000
- Antagonists Selective for NMDA Receptors Containing the NR2B SubunitCurrent Pharmaceutical Design, 1999
- Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal hornNeuropharmacology, 1999
- Developmental and regional expression in the rat brain and functional properties of four NMDA receptorsPublished by Elsevier ,1994
- An efficient conversion of nitriles to amidinesTetrahedron Letters, 1990